Trials / Unknown
UnknownNCT06245980
Role of SGLT2I in Patients With Myocardial Infarction
Role of SGLT2I in Diabetic Patients With Myocardial Infarction
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,200 (estimated)
- Sponsor
- Dongying Zhang · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Role of sglt2I in diabetic patients with myocardial infarction
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SGLT2 inhibitor | According to whether SGLT2i was used |
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2024-02-28
- Completion
- 2024-03-31
- First posted
- 2024-02-07
- Last updated
- 2024-02-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06245980. Inclusion in this directory is not an endorsement.